Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Advanced Lung Cancer: A Year in Review

EP. 1: Work-Up and Management of Nondriver Metastatic Lung Cancer

April 13th 2020

EP. 2: Therapy Approach for PD-L1 Over 50% Lung Cancer

April 13th 2020

EP. 3: Progression on Immunotherapy: Treatment Approach

April 13th 2020

EP. 4: PD-L1 Less Than 49%: Available Treatments

April 13th 2020

EP. 5: Immunotherapy and Brain Metastatic Lung Cancer

April 13th 2020

EP. 6: How Long to Continue Immunotherapy

April 13th 2020

EP. 7: The IMpower150 Regimen

April 13th 2020

EP. 8: When to Use the CheckMate-227 Regimen

April 13th 2020

EP. 9: Lung Cancer Molecular Testing Protocol

April 13th 2020

EP. 10: Upfront Targeted Treatment Approach

April 13th 2020

EP. 11: Oligometastatic and Small Cell Transformation Management

April 13th 2020

EP. 12: When to Re-Treat with Osimertinib

April 13th 2020

EP. 13: ALK-Rearranged & MET Exon 14 NSCLC Treatment Options

April 13th 2020

EP. 14: Brain Metastatic NSCLC: Targeted Therapy Approach

April 13th 2020

EP. 15: Unresectable Stage III Lung Cancer Management

April 13th 2020

EP. 16: Stage III NSCLC: When to Start Durvalumab

April 13th 2020

EP. 17: Stage III NSCLC Progression Treatment Strategy

April 13th 2020

EP. 18: Small-Cell Lung Cancer: The IMpower133 and CASPIAN trials

April 13th 2020

EP. 19: Limited-Stage SCLC: Is Immunotherapy an Option?

April 13th 2020

EP. 20: The Future of Lung Cancer Management

April 13th 2020
Advertisement
Advertisement

Trending on OncLive

1

FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC

2

PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings

3

META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL

4

Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL

5

Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us